A new trading day began on Tuesday, with Ventyx Biosciences Inc (NASDAQ: VTYX) stock price up 1.40% from the previous day of trading, before settling in for the closing price of $2.15. VTYX’s price has ranged from $1.79 to $15.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 34.66%. With a float of $54.69 million, this company’s outstanding shares have now reached $59.24 million.
The firm has a total of 80 workers. Let’s measure their productivity. In terms of profitability, gross margin is -29.37%, operating margin of -17061.06%, and the pretax margin is -15920.26%.
Ventyx Biosciences Inc (VTYX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Ventyx Biosciences Inc is 22.62%, while institutional ownership is 72.61%. The most recent insider transaction that took place on Apr 02 ’24, was worth 8,921. In this transaction CHIEF BUSINESS OFFICER of this company sold 1,651 shares at a rate of $5.40, taking the stock ownership to the 284,999 shares. Before that another transaction happened on Apr 02 ’24, when Company’s CHIEF SCIENTIFIC OFFICER sold 1,651 for $5.40, making the entire transaction worth $8,921. This insider now owns 264,998 shares in total.
Ventyx Biosciences Inc (VTYX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 34.66% per share during the next fiscal year.
Ventyx Biosciences Inc (NASDAQ: VTYX) Trading Performance Indicators
Here are Ventyx Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 14.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.79, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.22 in one year’s time.
Technical Analysis of Ventyx Biosciences Inc (VTYX)
Analysing the last 5-days average volume posted by the [Ventyx Biosciences Inc, VTYX], we can find that recorded value of 0.79 million was lower than the volume posted last year of 2.07 million. As of the previous 9 days, the stock’s Stochastic %D was 11.85%. Additionally, its Average True Range was 0.14.
During the past 100 days, Ventyx Biosciences Inc’s (VTYX) raw stochastic average was set at 27.46%, which indicates a significant increase from 16.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.75% in the past 14 days, which was lower than the 80.18% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.24, while its 200-day Moving Average is $3.57. Now, the first resistance to watch is $2.21. This is followed by the second major resistance level at $2.23. The third major resistance level sits at $2.27. If the price goes on to break the first support level at $2.15, it is likely to go to the next support level at $2.11. Now, if the price goes above the second support level, the third support stands at $2.09.
Ventyx Biosciences Inc (NASDAQ: VTYX) Key Stats
With a market capitalization of 154.06 million, the company has a total of 70,669K Shares Outstanding. Currently, annual sales are 0 K while annual income is -192,960 K. The company’s previous quarter sales were 0 K while its latest quarter income was -31,950 K.
